Fathima Paruk to Microbial Sensitivity Tests
This is a "connection" page, showing publications Fathima Paruk has written about Microbial Sensitivity Tests.
Connection Strength
0,050
-
Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris: Results from a Phase 2 Trial. Antimicrob Agents Chemother. 2023 05 17; 67(5):e0141922.
Score: 0,050